Tysabri treatment to Scots with multiple sclerosis (MS)
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
Tysabri treatment to Scots with multiple sclerosis (MS)

Multiple Sclerosis :: Tysabri treatment to Scots with multiple sclerosis (MS)
The MS Trust is dismayed by the SMC decision to deny this treatment to around 1,000 Scots living with rapidly deteriorating MS, by banning the drug Tysabri (natalizumab).
The Chief Executive of the MS Trust, Chris Jones comments: "We share the sadness of Scots with MS at this decision, particularly those for whom Tysabri offered their only chance of holding back this cruel disease. Clinicians will be prevented from prescribing an effective licensed treatment to people in need. We urge people with MS to continue fighting for Tysabri on an individual basis."
SMC decisions are based on cost-effectiveness, using the cost per quality adjusted life year (QALY). The QALY is a health economic formula which tries to determine the value of a treatment to a person's life, not the actual cost of providing the drug. The cut-off point used by the SMC is not clear, although it has been estimated between ?20-30,000 per QALY.
Chris Jones comments: "Accountancy has trumped clinical evidence with this decision. For a well defined group of people with MS, where the disease is running out-of-control, this drug is highly effective, leading to 60-70% reductions in relapses. Only an economist could make that sound expensive.
(
Multiple Sclerosis :: Tysabri treatment to Scots with multiple sclerosis (MS) published at
SpiritIndia on Wednesday, December 13, 2006)
Search more information on
Multiple SclerosisRecently posted related articles on Multiple Sclerosis :
- Multiple Sclerosis :: Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
- Multiple Sclerosis :: MS that runs in families appears more severe than non-familial MS
- Multiple Sclerosis :: Accentia announces investigational new drug application for Revimmune for refractory MS
- Multiple Sclerosis :: Antibody leads to repair of myelin sheath in lab study of multiple sclerosis and related disorders
- Smoking :: Smoking has no effect on progression of multiple sclerosis
- Multiple Sclerosis :: Patients own stem cells injected to treat multiple sclerosis
- Multiple Sclerosis :: Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients
- Multiple Sclerosis :: Waddell Center Experts Conduct Multiple Sclerosis Symposium
- MRI :: New MRI finding sheds light on multiple sclerosis disease progression
- Multiple Sclerosis :: Fish oil might help multiple sclerosis patients
»»
Healthcare :: Licensing Opportunities for Rare Disease Technologies««
Healthcare :: USDA Awards Nearly $1 Million in Food Stamp Outreach GrantsThe information provided on
SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health,
Business,
Science,
Sports,
Entertainment,
Technology
©2002-2009 SpiritIndia.com